Louis J. Ignarro, Ph.D., Delivered the 2nd Annual 'Distinguished Lecture in Basic Science' at Heart Failure Society of America 12th Annual Meeting

    Session to Highlight Excellence in Basic Science

    TORONTO, Sept. 21 /CNW/ -- At the 12th Annual Scientific Meeting of the
Heart Failure Society of America (HFSA) today Dr. Louis J. Ignarro, 1998 Nobel
Prize winner in Physiology or Medicine for discovering the signaling
properties of nitric oxide, was the featured speaker in the Excellence in
Basic Science Session.  He was presented with the 2nd Distinguished Lecture
Award in Basic Science immediately following his presentation "Nitric Oxide as
a unique signaling molecule in Physiology". This scientific session is the
highlight basic science session at the HFSA Annual Scientific Meeting.
    Dr. Ignarro's presentation focused on the discovery of nitric oxide, a
gaseous neurotransmitter that naturally occurs in humans and found to have
health benefits of great proportions. Nitric oxide works to increase the
body's blood flow, helping to keep blood vessels dilated and prevent blood
clotting, which in turn provides a defense mechanism against high blood
pressure, stroke and cardiac complication, such as heart attacks. It was
discovered while properties of nitro glycerin were being examined, leading to
findings that the body converts nitro glycerin into nitric oxide.
    "We are honored to have Dr. Ignarro give the Distinguished Lecture in
Basic Science at this year's HFSA Annual Scientific Meeting," said Dr. Barry
Greenberg, HFSA President, and Professor of Medicine, and Director, Advanced
Heart Failure Treatment Program, University of California, San Diego.
    Dr. Ignarro (Distinguished Professor of Pharmacology, UCLA) is the
co-recipient of the 1998 Nobel Prize in Physiology or Medicine for discovering
the signaling properties of nitric oxide, which is perhaps best known as the
medical breakthrough that later led to the development of the drug Viagra. Dr.
Ignarro has published numerous articles on his research, and is the founder of
the Nitric Oxide Society and founder and editor-in-chief of "Nitric Oxide
Biology and Chemistry." In 1998 he received the Basic Research Prize of the
American Heart Association for his contributions in the field and advancement
of cardiovascular science. Dr. Ignarro is an inductee of the National Academy
of Sciences and the American Academy of Arts and Sciences.
    For a complete list of annual meeting sessions or for details on
attending the conference, call (617) 226-7192 or visit www.hfsa.org and click
on Annual Scientific Meeting. There is no registration fee for accredited
journalists. Interview areas will be available on-site in addition to a
fully-staffed press room with phone and internet accessibility.
    About Heart Failure
    Heart failure is a progressive condition in which the heart muscle
becomes weakened after it is injured from heart attack or high blood pressure
and gradually loses its ability to pump enough blood to supply the body's
needs. Many people are not aware they have heart failure because the symptoms
are often mistaken for signs of getting older. Heart failure affects from 4.6
to 4.8 million individuals in the United States. Demographic and clinical
evidence strongly suggest the prevalence of heart failure will increase
throughout the next decade. Ten to 15 years ago heart failure was considered a
"death sentence;" however, recent advances in treatment have shown that early
diagnosis and proper care in early stages of the condition are key to slowing,
stopping or in some cases reversing progression, improving quality of life,
and extending life expectancy. For more information on heart failure, please
visit www.abouthf.org.
    About the Heart Failure Society of America
    The Heart Failure Society of America (HFSA) is a nonprofit educational
organization, founded in 1994 as the first organized association of heart
failure experts. Today HFSA has over 1,700 members and provides a forum for
all those interested in heart function, heart failure research and patient
care. The Society also serves as a resource for governmental agencies (FDA,
NIH, NHLBI, CMS). The HFSA Annual Scientific Meeting is designed to highlight
recent advances in the development of strategies to address the complex
epidemiological, clinical and therapeutic issues of heart failure. Additional
information on HFSA can be found at www.hfsa.org.

For further information:

For further information: Kaitlyn Siner, +1-617-226-7192, cell,
+1-401-339-0954, ksiner@bellpottingerusa.com, or Ben Hendricks,
+1-617-226-7183, cell, +1-919-522-2978, bhendricks@bellpottingerusa.com, both
for HFSA Web Site: http://www.hfsa.org                

Organization Profile


More on this organization

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890